Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Omar Atiq to Female

This is a "connection" page, showing publications Omar Atiq has written about Female.

 
Connection Strength
 
 
 
0.079
 
  1. Atiq O, Atiq SO, Atiq ZO, Patel V, Atiq MO, Atiq OT. Pembrolizumab-Induced Cold Agglutinin Disease. Am J Case Rep. 2020 Sep 05; 21:e924283.
    View in: PubMed
    Score: 0.044
  2. Adkins D, Ley J, Atiq O, Powell S, Spanos WC, Gitau M, Rigden C, Palka K, Liu J, Oppelt P. Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial. Oral Oncol. 2021 04; 115:105173.
    View in: PubMed
    Score: 0.011
  3. Wongsurawat T, Nakagawa M, Atiq O, Coleman HN, Jenjaroenpun P, Allred JI, Trammel A, Puengrang P, Ussery DW, Nookaew I. An assessment of Oxford Nanopore sequencing for human gut metagenome profiling: A pilot study of head and neck cancer patients. J Microbiol Methods. 2019 11; 166:105739.
    View in: PubMed
    Score: 0.010
  4. Dunn A, Broadfoot BG, Hunt J, Kaley JR, Atiq O, Gutta NB, Wang X, Gardner JM, Shalin SC. Metastatic laryngeal large cell neuroendocrine carcinoma: A rare case of presentation and extreme tumor burden. J Cutan Pathol. 2018 Mar; 45(3):229-233.
    View in: PubMed
    Score: 0.009
  5. Kozuch PS, Rocha-Lima CM, Dragovich T, Hochster H, O'Neil BH, Atiq OT, Pipas JM, Ryan DP, Lenz HJ. Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study. J Clin Oncol. 2008 May 10; 26(14):2320-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.